Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell.

× No keyword cloud information.

9 in total

1. Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines.

Authors: Chung Soo Lee; Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim
Journal: Mol Cell Biochem Date: 2009-12-18 Impact factor: 3.396

Review 2. Clinical implications of c-Kit mutations in acute myelogenous leukemia.

Authors: Muriel Malaise; Daniel Steinbach; Selim Corbacioglu
Journal: Curr Hematol Malig Rep Date: 2009-04 Impact factor: 3.952

3. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines.

Authors: Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim; Chung Soo Lee
Journal: Mol Cell Biochem Date: 2011-03-06 Impact factor: 3.396

4. Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discovery.

Authors: M H Ung; C-H Sun; C-W Weng; C-C Huang; C-C Lin; C-C Liu; C Cheng
Journal: Pharmacogenomics J Date: 2016-03-15 Impact factor: 3.550

5. Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression.

Authors: Chunrui Li; Jianfeng Zhou; Xueqiong Wu; Ye Tian; Jingniu Deng; Wenli Liu
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2009-10-11

6. Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status.

Authors: Min-Wu Chao; Li-Hsun Chang; Huang-Ju Tu; Chao-Di Chang; Mei-Jung Lai; Yi-Ying Chen; Jing-Ping Liou; Che-Ming Teng; Shiow-Lin Pan
Journal: Clin Epigenetics Date: 2019-05-29 Impact factor: 6.551

Review 7. HDAC Inhibitors in Acute Myeloid Leukemia.

Authors: Edurne San José-Enériz; Naroa Gimenez-Camino; Xabier Agirre; Felipe Prosper
Journal: Cancers (Basel) Date: 2019-11-14 Impact factor: 6.639

8. Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Authors: Cinzia Lanzi; Enrica Favini; Laura Dal Bo; Monica Tortoreto; Noemi Arrighetti; Nadia Zaffaroni; Giuliana Cassinelli
Journal: J Exp Clin Cancer Res Date: 2021-12-02

9. Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres.

Authors: Eno I Essien; Thomas P Hofer; Michael J Atkinson; Nataša Anastasov
Journal: Cells Date: 2022-02-23 Impact factor: 6.600

9 in total